New website: for the ongoing Phase II study named PROTACT

Oct 4., 2018 – Silenseed announced the new website for the ongoing Phase II study named PROTACT.  PROTACT, standing for Precise RNAi for Obtaining TArgeted Cancer Therapy, is an acronym that has been selected as for the Phase 2 SLSG12D-P2 study, in order to emphasize the power and hope behind the KRAS-LODER technology – very precise RNAi-based silencing of the well-known yet undruggable KRAS. Recently diagnosed patients with stage III pancreatic cancer can fill-in their details and see if are eligible and can join the trial.

Share this post